Free combination of dutasteride plus tamsulosin for the treatment of benign prostatic hyperplasia in South Korea: analysis of drug utilization and adverse events using the National Health Insurance Review and Assessment Service database

OBJECTIVE: To assess the use and safety of free combination therapy (dutasteride and tamsulosin), dutasteride monotherapy, or tamsulosin monotherapy in patients with benign prostatic hyperplasia (BPH). METHODS: This non-interventional retrospective cohort study used claims data from the Korea Health...

Descripción completa

Detalles Bibliográficos
Autores principales: Lulic, Zrinka, Son, Hwancheol, Yoo, Sang-Bae, Cunnington, Marianne, Kapse, Pratiksha, Miller, Diane, Cortes, Vanessa, Park, Suna, Bhak, Rachel H., Duh, Mei Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691067/
https://www.ncbi.nlm.nih.gov/pubmed/34933674
http://dx.doi.org/10.1186/s12894-021-00941-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691067/
https://www.ncbi.nlm.nih.gov/pubmed/34933674
http://dx.doi.org/10.1186/s12894-021-00941-1

Ejemplares similares